---
title: "Novo Nordisk AS's stock price fell by 2.3%, marking the fifth consecutive trading day of decline"
description: "Novo Nordisk AS's stock price fell by 2.3%, marking the fifth consecutive trading day of decline"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/258846545.md"
published_at: "2025-09-25T09:57:13.000Z"
---

# Novo Nordisk AS's stock price fell by 2.3%, marking the fifth consecutive trading day of decline

Novo Nordisk AS's stock price fell by 2.3%, marking the fifth consecutive trading day of decline

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/en/news/275652909.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/en/news/275789396.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/en/news/275761183.md) |
| Oppenheimer Asset Management Inc. Has $31.35 Million Stock Position in Novo Nordisk A/S $NVO | Oppenheimer Asset Management Inc. increased its stake in Novo Nordisk A/S by 14.4% in Q3, holding 565,007 shares valued  | [Link](https://longbridge.com/en/news/275287765.md) |
| Novo Nordisk confirms receipt of "untitled letter" from FDA on Wegovy pill television commercial | Novo Nordisk confirms receipt of "untitled letter" from FDA on Wegovy pill television commercial | [Link](https://longbridge.com/en/news/275349607.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.